GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

Clinical trial NCT00074022 · COMPLETED

Trial details

NCT number: NCT00074022
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Non-small Cell Lung Cancer Recurrent Prostate Cancer Stage III Prostate Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Stage IV Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-10-01
Primary completion: 2007-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.